Development and validation of machine learning tools for predicting postoperative complications in acute calculous cholecystitis
Updates in Surgery · 2026-11 · 78 (7) · 3043-3054
DOI: 10.1007/s13304-025-02476-8 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Updates in Surgery, online erschienen am 19.12.2025. Verfasst von Ottavia Cicerone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di scienze clinico-chirurgiche, diagnostiche e pediatriche, University of Pavia, Pavia, Italy. Hauptthemen laut MEDLINE: Cholecystitis, Acute, Postoperative Complications, Machine Learning, Cholecystectomy, Laparoscopic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Acute calculous cholecystitis (ACC) is a common gastrointestinal emergency, with early laparoscopic cholecystectomy (ELC) as the standard of care. However, the risk of postoperative complications remains significant. This study developed and validated two machine learning models-CholeSurgRisk I (preoperative) and CholeSurgRisk II (comprehensive)-to predict major postoperative complications in ACC. METHODS: A prospectively collected, multicenter database of 1,253 patients was retrospectively analyzed. Lasso regression identified key predictive variables among demographic, clinical, and perioperative factors. Three machine learning algorithms (Random Forest, XGBoost, Decision Tree) were trained and tested, comparing their performance via AUC-ROC. RESULTS: CholeSurgRisk I achieved an AUC-ROC of 0.8456, while incorporating intraoperative variables (CholeSurgRisk II) improved performance to 0.8903. To facilitate clinical use, a web-based tool - "CholeSurgRisk I" - was developed based on the preoperative model, providing real-time, patient-specific risk estimations. CONCLUSION: Machine learning enhances perioperative risk stratification in ACC. CholeSurgRisk I facilitates early preoperative assessment, whereas CholeSurgRisk II refines predictions by integrating intraoperative factors. The user-friendly application "CholeSurgRisk I" offers individualized complication risk forecasts, potentially aiding clinical decision-making and optimizing outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dipartimento di scienze clinico-chirurgiche, diagnostiche e pediatriche, University of Pavia, Pavia, Italy.
- Fondazione IRCCS Policlinico San Matteo, SC Chirurgia Generale 1, P.le Golgi 19, Pavia, 27100, Italy.
- Fondazione IRCCS Policlinico San Matteo, SC Radiologia, Pavia, Italy.
- Fondazione IRCCS Policlinico San Matteo, SC Anatomia Patologica, Pavia, Italy.
- Dipartimento di scienze clinico-chirurgiche, diagnostiche e pediatriche, University of Pavia, Pavia, Italy. m.maestri@smatteo.pv.it.
- Fondazione IRCCS Policlinico San Matteo, SC Chirurgia Generale 1, P.le Golgi 19, Pavia, 27100, Italy. m.maestri@smatteo.pv.it.
Zitieren
APA
Cicerone, O., Frassini, S., Gallotti, A., Vanoli, A., Ansaloni, L., Maestri, M., Fugazzola, P., S P Ri M A C C, & Collaborative Group (2026). Development and validation of machine learning tools for predicting postoperative complications in acute calculous cholecystitis. Updates in Surgery, 78(7), 3043-3054. https://doi.org/10.1007/s13304-025-02476-8
Vancouver
Cicerone O, Frassini S, Gallotti A, Vanoli A, Ansaloni L, Maestri M, et al. Development and validation of machine learning tools for predicting postoperative complications in acute calculous cholecystitis. Updates in Surgery. 2026;78(7):3043-3054. doi:10.1007/s13304-025-02476-8
BibTeX
@article{Cicerone2026,
author = {Cicerone, Ottavia and Frassini, Simone and Gallotti, Anna and Vanoli, Alessandro and Ansaloni, Luca and Maestri, Marcello and Fugazzola, Paola and S P Ri M A C C and Collaborative Group},
title = {Development and validation of machine learning tools for predicting postoperative complications in acute calculous cholecystitis},
journal = {Updates in Surgery},
year = {2026},
volume = {78},
number = {7},
pages = {3043--3054},
doi = {10.1007/s13304-025-02476-8}
}
EUVIMED